GlobeStar Therapeutics Corp Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GlobeStar Therapeutics Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2011 to Q4 2023.
  • GlobeStar Therapeutics Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was $42.8K, a 5.68% increase year-over-year.
  • GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $199K, a 39.1% decline from 2022.
  • GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $327K, a 51.6% decline from 2021.
  • GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $676K, a 204% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $42.8K +$2.3K +5.68% Oct 1, 2023 Dec 31, 2023 10-Q 2024-03-12
Q4 2022 $40.5K -$105K -72.1% Oct 1, 2022 Dec 31, 2022 10-Q 2024-03-12
Q4 2021 $145K +$115K +383% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q4 2020 $30K -$2K -6.25% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q4 2019 $32K -$3K -8.57% Oct 1, 2019 Dec 31, 2019 10-Q 2021-01-28
Q4 2018 $35K -$30K -46.2% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q4 2017 $65K +$47.5K +271% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-19
Q4 2016 $17.5K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-15
Q4 2014 $70.6K +$26K +58.2% Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-17
Q4 2013 $44.7K -$91.3K -67.1% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q4 2012 $136K +$94.2K +226% Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-21
Q4 2011 $41.7K Oct 1, 2011 Dec 31, 2011 10-Q/A 2013-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.